Saleh F, Karimi Rouzbahani A, Naghmehsanj Z, Molavi M A. Isolated Unilateral Orbital Myeloid Sarcoma (an Isolated Extra Medullary Myeloid Leukemia): A Case Report. J. Pediatr. Rev 2026; 14 (2) :207-212
URL:
http://jpr.mazums.ac.ir/article-1-623-en.html
1- Department of Pediatric Hematology Oncology, Children’s Clinical Research Development Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
2- Department of Urology, Western Health, Melbourne, Australia. & Surgery Education and Researching Network (SERGN), Universal Scientific Education and Research Network (USERN), Khorramabad, Iran.
3- Department of Pediatrics, Pediatric Hospital, Bandar Abbas, Iran
4- Department of Pediatric Hematology Oncology, Children’s Clinical Research Development Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran , shayanmolavi@yahoo.com
Abstract: (7 Views)
Background: Myeloid sarcoma (MS) is a rare condition characterized by extramedullary proliferation of myeloid blasts in various tissues, with or without bone marrow involvement. It is strongly associated with acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and myelodysplastic syndromes (MDS), and is often misdiagnosed as lymphoma.
Case Presentation: We herein report a case of isolated unilateral orbital MS presenting as extramedullary infiltration of myeloid blasts without bone marrow involvement in a patient from Iran.
Conclusions: Patients with isolated MS who receive AML-type chemotherapy may experience more favorable outcomes compared to patients who have AML with or without associated MS.
Type of Study:
Case Report and Review of Literature |
Subject:
Pediatrics Received: 2024/04/20 | Accepted: 2025/12/7 | Published: 2026/04/3